Biltmore Family Office LLC bought a new position in SPDR S&P Pharmaceuticals (NYSEARCA:XPH) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 31,650 shares of the company’s stock, valued at approximately $1,377,000.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Oliver Luxxe Assets LLC increased its stake in shares of SPDR S&P Pharmaceuticals by 5.6% in the 4th quarter. Oliver Luxxe Assets LLC now owns 23,935 shares of the company’s stock worth $1,041,000 after acquiring an additional 1,280 shares during the last quarter. Worth Venture Partners LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals in the 4th quarter worth $226,000. Nicholas Hoffman & Company LLC. acquired a new stake in shares of SPDR S&P Pharmaceuticals in the 4th quarter worth $448,000. Equity Investment Corp acquired a new stake in shares of SPDR S&P Pharmaceuticals in the 4th quarter worth $469,000. Finally, Creative Planning acquired a new stake in shares of SPDR S&P Pharmaceuticals in the 4th quarter worth $500,000.

How to Become a New Pot Stock Millionaire

Shares of SPDR S&P Pharmaceuticals (NYSEARCA XPH) opened at $43.65 on Thursday. SPDR S&P Pharmaceuticals has a 52 week low of $39.78 and a 52 week high of $47.11. The stock has a market capitalization of $374.07 and a price-to-earnings ratio of 2.76.

TRADEMARK VIOLATION WARNING: “Biltmore Family Office LLC Takes $1.38 Million Position in SPDR S&P Pharmaceuticals (XPH)” was published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2018/03/15/biltmore-family-office-llc-takes-1-38-million-position-in-spdr-sp-pharmaceuticals-xph.html.

SPDR S&P Pharmaceuticals Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals (NYSEARCA:XPH).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.